MedTrace Logo

Clinical Study of Intermittent Positive Pressure Breathing (IPPB)

NCT00000565 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-04-14

No results posted yet for this study

Summary

To evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of ambulatory outpatients with chronic obstructive pulmonary disease. The evaluation compared the use of IPPB with use of a powered nebulizer.

Conditions

Interventions

PROCEDURE

intermittent positive-pressure breathing

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Nicholas Anthonisen · University of Manitoba

  • John Hodgkin · Loma Linda University Medical Center

  • Philip Hopewell · San Francisco General Hospital

  • David Levin · University of Oklahoma

  • Paul Stevens · Baylor College of Medicine

  • Elizabeth Wright · George Washington University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
30 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1976-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000565 on ClinicalTrials.gov